Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Outcomes for Double Hit Lymphoma Patients Identified Via Routine Vs Selective Testing for MYC Rearrangement

Zachary AK Frosch, MD, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Stefan K. Barta, MD MRCP, MS, James N. Gerson, MD, Elise A. Chong, MD, Emily C. Ayers, MD, Joanna M Rhodes, MD, Alexa Koike, Jennifer J.D. Morrissette, PhD, Daniel J. Landsburg, MD

Blood (2019) 134 (Supplement_1): 1607.

https://doi.org/10.1182/blood-2019-125944

Published: 2019

Journal Articles

Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas

Hidong Kim, MD, Laura Harper, MD, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Patrick Johnston, Thomas E. Witzig, MD, Cristine Allmer, BS, Matthew J. Maurer, MS, James R. Cerhan, MD PhD, Jason Young, MD, Gita Thanarajasingam, MD

Blood (2018) 132 (Supplement 1): 5401.

https://doi.org/10.1182/blood-2018-99-117711

Published: 2018

Journal Articles

Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA

Blood (2018) 132 (Supplement 1): 781.

https://doi.org/10.1182/blood-2018-99-112403

Published: 2018

Journal Articles

Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma

Suvi-Katri Leivonen, PhD, Marjukka Pollari, MD, Oscar Brück, Teijo Pellinen, PhD, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, MD PhD, Pirkko-Liisa Kellokumpu-Lehtinen, MD prof, Satu Mustjoki, MDPhD, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 4027.

https://doi.org/10.1182/blood.V130.Suppl_1.4027.4027

Published: 2017

Journal Articles

High Amount of PD-L1+ Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

Marjukka Pollari, MD, Oscar Brück, Suvi-Katri Leivonen, PhD, Teijo Pellinen, PhD, Pauli Vähämurto, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, MD PhD, Pirkko-Liisa Kellokumpu-Lehtinen, MD prof, Satu Mustjoki, MDPhD, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 2761.

https://doi.org/10.1182/blood.V130.Suppl_1.2761.2761

Published: 2017

Journal Articles

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma with 9p24.1 Copy Number Alterations

Yucai Wang, MD, Kerstin Wenzl, PhD, Matthew J Maurer, MS, Yan W Asmann, PhD, Susan L Slager, PhD, Thomas E Witzig, MD, Stephen M Ansell, MD PhD, Andrew L Feldman, MD, Brian K Link, MD, Grzegorz S Nowakowski, MD, James R. Cerhan, MD PhD, Anne J Novak, PhD

Blood (2017) 130 (Supplement 1): 196.

https://doi.org/10.1182/blood.V130.Suppl_1.196.196

Published: 2017

Journal Articles

Stage I Lymphoma: Difference in Survival Outcome By Site of Involvement

Dai Chihara, MDPhD, Yasuhiro Oki, MD, Michelle A. Fanale, MD, Jason R. Westin, MD, Loretta Nastoupil, MD, Sattva S. Neelapu, MD, Luis E. Fayad, Nathan H. Fowler, MD, Chan Yoon Cheah, MBBS

Blood (2017) 130 (Supplement 1): 1569.

https://doi.org/10.1182/blood.V130.Suppl_1.1569.1569

Published: 2017

Journal Articles

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

Lakshmi Nayak, Fabio M. Iwamoto, Ann LaCasce, Srinivasan Mukundan, Margaretha G. M. Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp

Blood (2017) 129 (23): 3071–3073.

https://doi.org/10.1182/blood-2017-01-764209

Published: 2017

Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)

Parikshit Padhi, MD, Abhishek Chilkulwar, MD, Cyrus Khan, MD, Monank Patel, PharmD, BCOP, John Lister, MD, Xiaoqin Tang, PhD Director of Biostatistics

Blood (2016) 128 (22): 5410.

https://doi.org/10.1182/blood.V128.22.5410.5410

Published: 2016

Journal Articles

Primary Testicular Lymphoma:a Single Center Experience and Literature Review

Ling Li, MDPhD, Fangwen Zhang, graduate student, Ken H. Young, MD PhD, Wenjing Duan, graduate student, Zhaoming Li, MD PhD, Jiaqin Yan, MD PhD, Xiaorui Fu, MD PhD, Lei Zhang, MD PhD, Xin Li, MD PhD, Zhenchang Sun, MD PhD, Xudong Zhang, MD PhD, Yu Chang, MD, Feifei Nan, MD PhD, Mingzhi Zhang, MD PhD

Blood (2016) 128 (22): 5415.

https://doi.org/10.1182/blood.V128.22.5415.5415

Published: 2016

Journal Articles

In Silico and Functional Characterization of TBL1XR1 as a Tumor Suppressor in Large B-Cell Lymphomas

Bjoern Chapuy, MD PhD, Atanas Kamburov, PhD, Caroline A Coughlin, Chip Stewart, PhD, Andrew Dunford, Miyuki Aono, Jens Loeber, Christopher Sauer, Arthur Su, Margaretha G M Roemer, Scott J Rodig, Gad Getz, PhD, Margaret A. Shipp, MD

Blood (2016) 128 (22): 612.

https://doi.org/10.1182/blood.V128.22.612.612

Published: 2016

Journal Articles

Nivolumab (Anti-PD1) Therapy for Relapsed/ Refractory Primary Central Nervous System Lymphoma and Primary Testicular Lymphoma

Lakshmi Nayak, MD, Fabio Iwamoto, MD, Ann S. LaCasce, MD, Srinivasan Mukundan, Jr., Margaretha G M Roemer, Bjoern Chapuy, MD PhD, Philippe Armand, MD PhD, Scott J. Rodig, Margaret A. Shipp, MD

Blood (2016) 128 (22): 930.

https://doi.org/10.1182/blood.V128.22.930.930

Published: 2016

Journal Articles

MYD88, CD79B, and CD79A Gene Mutations in CD5-Positive Diffuse Large B-Cell Lymphoma

Toshifumi Takeuchi, MD, Motoko Yamaguchi, MD PhD, Kyoko Kobayashi, MD PhD, Kana Miyazaki, MD PhD, Hiroshi Imai, MD PhD, Ryoichi Ono, MD PhD, Isao Tawara, MD PhD, Tetsuya Nosaka, MD PhD, Kyosuke Tanaka, MD PhD, Naoyuki Katayama, MD PhD

Blood (2016) 128 (22): 1861.

https://doi.org/10.1182/blood.V128.22.1861.1861

Published: 2016

Journal Articles

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Beata Ostrowska, MD PhD, Martyna Kotarska, MD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Anna Borawska, MD PhD, Agnieszka Druzd-Sitek, MD PhD, Ewa Paszkiewicz-Kozik, MD PhD, Lidia Poplawska, Grzegorz Rymkiewicz, MD PhD, Jan Walewski, MD PhDProf

Blood (2015) 126 (23): 5040.

https://doi.org/10.1182/blood.V126.23.5040.5040

Published: 2015

Journal Articles

Dose Intensification with Rituximab, MTX and CHOP Results in Superior Results for Young High Risk DLBCL Patients Than Primary Autologous Transplantation

Reinhard Marks, Tim Strüssmann, Alexander Baumgarten, Jürgen Finke, MD

Blood (2015) 126 (23): 3967.

https://doi.org/10.1182/blood.V126.23.3967.3967

Published: 2015

Journal Articles

Clinical and Biological Features of Primary Testicular B-Cell Lymphoma - a Single-Institution Study of 89 Cases

Sanam Loghavi, MD, Zijun Yidan Xu-Monette, PhD, Luis Fayad, MD, Larry W Kwak, MD PhD, Bouthaina S. Dabaja, MD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD

Blood (2014) 124 (21): 3036.

https://doi.org/10.1182/blood.V124.21.3036.3036

Published: 2014

Journal Articles

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Blood (2014) 124 (21): 74.

https://doi.org/10.1182/blood.V124.21.74.74

Published: 2014

Journal Articles

Primary testicular lymphoma

Chan Y. Cheah, Andrew Wirth, John F. Seymour

Blood (2014) 123 (4): 486–493.

https://doi.org/10.1182/blood-2013-10-530659

Published: 2014

Journal Articles

High-Dose Methotrexate In The Treatment Of Primary Testicular Lymphoma

Marika Reinius, BA, MB BChir, Saif S Ahmad, MBChB (Hons), MRCP, Charles Crawley, MD, Michael V Williams, MA, MB BChir, MD, FRCP, FRCR, Jennie Wimperis, MB BS, DM (Oxon), FRCP, FRCPath, George A Follows, MD, PhD

Blood (2013) 122 (21): 5108.

https://doi.org/10.1182/blood.V122.21.5108.5108

Published: 2013

Journal Articles

Clinicopathologic Characteristics and Clinical Outcomes in Patients with Testicular Non-Hodgkin Lymphoma

Jeongseok Kim, MD, Dok Hyun Yoon, MD, Ji Hyun Park, MD, Il Young Jang, MD, Shin Kim, RN, Kyoungmin Lee, RN, Eun Hee Kang, RN, Jooryung Huh, MD, Chan-Sik Park, MD, Cheolwon Suh, MD

Blood (2012) 120 (21): 5111.

https://doi.org/10.1182/blood.V120.21.5111.5111

Published: 2012

NARROW

Outcomes for Double Hit Lymphoma Patients Identified Via Routine Vs Selective Testing for MYC Rearrangement

Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas

Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA

Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma

High Amount of PD-L1+ Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma with 9p24.1 Copy Number Alterations

Stage I Lymphoma: Difference in Survival Outcome By Site of Involvement

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)

Primary Testicular Lymphoma:a Single Center Experience and Literature Review

In Silico and Functional Characterization of TBL1XR1 as a Tumor Suppressor in Large B-Cell Lymphomas

Nivolumab (Anti-PD1) Therapy for Relapsed/ Refractory Primary Central Nervous System Lymphoma and Primary Testicular Lymphoma

MYD88, CD79B, and CD79A Gene Mutations in CD5-Positive Diffuse Large B-Cell Lymphoma

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Dose Intensification with Rituximab, MTX and CHOP Results in Superior Results for Young High Risk DLBCL Patients Than Primary Autologous Transplantation

Clinical and Biological Features of Primary Testicular B-Cell Lymphoma - a Single-Institution Study of 89 Cases

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Primary testicular lymphoma

High-Dose Methotrexate In The Treatment Of Primary Testicular Lymphoma

Clinicopathologic Characteristics and Clinical Outcomes in Patients with Testicular Non-Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only